| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/28/2008 | US20080052787 Chimeric gene constructs for generation of fluorescent transgenic ornamental fish |
| 02/28/2008 | US20080051571 Silyl Linker For Solid-Phase Synthesis Of Nucleic Acid |
| 02/28/2008 | US20080051570 Stress-inducible plant promoters |
| 02/28/2008 | US20080051569 Expression vector comprising nucleotide sequences coding bacillus delta -endotoxin for use in transformation and generation of insect resistant corn |
| 02/28/2008 | US20080051568 Capture moieties for nucleic acids and uses thereof |
| 02/28/2008 | US20080051565 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 02/28/2008 | US20080051556 Novel PTP-20, PCP-2, BDP1, CLK, and SIRP proteins and related products and methods |
| 02/28/2008 | US20080051555 Support Having Affinity for Antibody |
| 02/28/2008 | US20080051361 Intraocular pressure-related conditions, namely glaucoma; administering to the eye of the patient an interfering RNA molecule that attenuates expression of the GREM1 mRNA via RNA interference |
| 02/28/2008 | US20080051360 Pkc ligands and polynucleotides encoding pkc ligands |
| 02/28/2008 | US20080051359 Antisense oligonucleotide modulation of stat3 expression |
| 02/28/2008 | US20080051356 Truncated 24kDa basic fibroblast growth factor |
| 02/28/2008 | US20080051354 Human schwannoma cell line |
| 02/28/2008 | US20080051349 Peptide antagonists of zonulin and methods for use of the same |
| 02/28/2008 | US20080051347 Tumour-associated peptides binding to mhc-molecules |
| 02/28/2008 | US20080051344 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 02/28/2008 | US20080051339 Modulators of pharmacological agents |
| 02/28/2008 | US20080051338 98 Human Secreted Proteins |
| 02/28/2008 | US20080051337 Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease |
| 02/28/2008 | US20080051336 Relaxin-3 Chimeric Polypeptides and Their Preparation and Use |
| 02/28/2008 | US20080051328 Novel Muscle Growth Regulator |
| 02/28/2008 | US20080051318 Detecting single nucleotide polymorphism ; kits; drug screening; neurodegenerative disease |
| 02/28/2008 | US20080051299 DNA-protein fusions and uses thereof |
| 02/28/2008 | US20080051295 Method Of Detecting Nucleic Acid Using Amplification On An Array |
| 02/28/2008 | US20080051293 Method for analyzing base sequence of nucleic acid |
| 02/28/2008 | US20080050840 Novel protein kinase molecules and uses therefor |
| 02/28/2008 | US20080050826 Method for improving corn starch extractability |
| 02/28/2008 | US20080050825 Method for Production of Transgenic Plants with Increased Pathogenic Resistance by Altering the Content and/or Activity of Actin-Depolymerising Factors |
| 02/28/2008 | US20080050824 Polynucleotide Encoding a Maize Herbicide Resistance Gene and Methods for Use |
| 02/28/2008 | US20080050823 Polynucleotide Encoding a Maize Herbicide Resistance Gene and Methods for Use |
| 02/28/2008 | US20080050822 Polynucleotide Encoding a Maize Herbicide Resistance Gene and Methods for Use |
| 02/28/2008 | US20080050821 Alfalfa Plants Having Improved Fast Recovery After Harvest and Methods for Producing Same |
| 02/28/2008 | US20080050820 Casein kinase stress-related polypeptides and methods of use in plants |
| 02/28/2008 | US20080050819 Constructs for Marker Excision Based on Dual-Function Selection Marker |
| 02/28/2008 | US20080050818 Polynucleotide Encoding a Maize Herbicide Resistance Gene and Methods for Use |
| 02/28/2008 | US20080050811 Testicular carnitine transporter and its gene |
| 02/28/2008 | US20080050810 VARIANTS OF HUMANIZED ANTI-CARCINOMA MAb CC49 |
| 02/28/2008 | US20080050809 Novel human kinases and polynucleotides encoding the same |
| 02/28/2008 | US20080050808 DNA modular cloning vector plasmids and methods for their use |
| 02/28/2008 | US20080050807 Gene encoding alkaline liquefying alpha-amylase |
| 02/28/2008 | US20080050797 Transferase for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 02/28/2008 | US20080050796 Polyketide synthetase activity; vectors; host cells |
| 02/28/2008 | US20080050794 Optoinjection methods |
| 02/28/2008 | US20080050791 Pufa polyketide synthase systems and uses thereof |
| 02/28/2008 | US20080050790 Pufa polyketide synthase systems and uses thereof |
| 02/28/2008 | US20080050788 Gamma-Butyrobetaine Hydroxylase Originated From Neurospora Crassa |
| 02/28/2008 | US20080050785 Method for Producing an L-Amino Acid |
| 02/28/2008 | US20080050784 Ability to produce L-glutamic acid, valine, threaonine, histidine or proline is incrreased by increasing expression of a specific protein, e.g., by increasing the copy number of the DNA coding for the protein |
| 02/28/2008 | US20080050777 Methods for Expression and Purification of Recombinant Human Growth Hormone |
| 02/28/2008 | US20080050775 Methods for Recovering Products From Plants |
| 02/28/2008 | US20080050774 Computer-based system for monitoring differential expression; host cells |
| 02/28/2008 | US20080050773 Dipeptide forming enzyme; pharmaceutical and food supplement |
| 02/28/2008 | US20080050770 Method for the production and purification of adenoviral vectors |
| 02/28/2008 | US20080050767 for diseases relating to energy metabolism, including obesity, dyslipidemia, insulin resistance syndrome, and type 2 diabetes |
| 02/28/2008 | US20080050766 Plasmid Having Response to Dioxins, Transgenic Cell for Measuring Dioxins, Dioxins Sensing Method and Biosensor Using the Same |
| 02/28/2008 | US20080050763 Identification of substances that inhibit nemo oligomerization |
| 02/28/2008 | US20080050760 Compositions and methods to co-localize luminophores with luminescent proteins |
| 02/28/2008 | US20080050759 Screening Assay for Anti-Bacterial Compounds |
| 02/28/2008 | US20080050758 Genetic engineering; oligonucleotide detector; identification and isolation of novel DNA; transmembrane domain-deleted or transmembrane domain-inactivated protein; soluble extracellular domains; PRO polypeptide; cancer detection |
| 02/28/2008 | US20080050753 Lipid engineering for analyzing a structure, or functions of a ceramide, diseases associated with the ceramide metabolism; controlling an amount of ceramide in a cell |
| 02/28/2008 | US20080050751 Nonhuman model animal of th2-mediated hyperimmune response |
| 02/28/2008 | US20080050745 Sugar chain synthesizing agent having beta1,3-N-acetyglucosaminyltransferase activity |
| 02/28/2008 | US20080050744 Methods and compositions involving mirna and mirna inhibitor molecules |
| 02/28/2008 | US20080050742 Methods and Reagents for Combined PCR Amplification |
| 02/28/2008 | US20080050722 Novel Mirna Molecules Isolated from Human Embryonic Stem Cell |
| 02/28/2008 | US20080050720 Methods for Using a Sterol Biosynthesis Pathway Reporter Gene to Screen for Antifungal or Lipid Lowering Compounds |
| 02/28/2008 | US20080050719 Gene expression profiles in liver disease |
| 02/28/2008 | US20080050716 Methods for preserving organs and tissues |
| 02/28/2008 | US20080050506 Production of high tryptophan maize by chloroplast targeted expression of anthranilate synthase |
| 02/28/2008 | US20080050505 Phosphopantetheinyl transferases from bacteria |
| 02/28/2008 | US20080050503 Expression of human milk proteins in transgenic plants |
| 02/28/2008 | US20080050470 Cacao endoproteinases and production of cocoa flavor from same |
| 02/28/2008 | US20080050460 Uses of lectin-conotoxin |
| 02/28/2008 | US20080050403 Production of viruses, viral isolates and vaccines |
| 02/28/2008 | US20080050401 Rescue of Influenza Virus |
| 02/28/2008 | US20080050399 Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins |
| 02/28/2008 | US20080050393 Novel nucleic acids and polypeptides |
| 02/28/2008 | US20080050388 Specified complementary determining region (CRD) amino acid sequences; specific binding activity for a cryptic collagen epitope; angiogenesis inhibition, antimetastasis, and tumor-targeted therapy uses |
| 02/28/2008 | US20080050386 Novel proteins, gene encoding the same and method of utilization thereof |
| 02/28/2008 | US20080050378 A ribonucleotide sequence corresponding to a gene KIF11 target sequence, where the antisense strand comprises a ribonucleotide sequence complementary to the sense strand; sense/anntisense strands hybridize to form double-stranded molecule which inhibits cell expression of KIf11 (SEQ ID NO: 34) |
| 02/28/2008 | US20080050377 consensus sequences and specific sequences for antibodies that specifically bind to STOP-1; angiogenesis and vasculogenesis; antitumor agents |
| 02/28/2008 | US20080050374 Immunoglobulin fusion for prevention and treatment of cell proliferative disorders |
| 02/28/2008 | US20080050372 Inhibition of alpha-2 hs glycoprotein (ahsg/fetuin) in obesity and insulin control of glucose homeostasis |
| 02/28/2008 | US20080050371 Comprises immunoglobulin for treating and preventing inflammation, thrombocytopenia and/or autoimmune hemolytic anemia |
| 02/28/2008 | US20080050370 Stabilized polypeptide compositions |
| 02/28/2008 | US20080050369 Therapeutic applications of T-BAM (CD40L) technology to treat diseases involving smooth muscle cells |
| 02/28/2008 | US20080050368 Humanized immunoglobulin reactive with B7 molecules and methods of treatment therewith |
| 02/28/2008 | US20080050367 Humanized antibodies that recognize beta amyloid peptide |
| 02/28/2008 | US20080050365 Anti-Hiv Antibody |
| 02/28/2008 | US20080050363 Novel nucleic acid molecules encoding opioid growth factor receptors |
| 02/28/2008 | US20080050362 Methods of Inhibiting Tumor Cell Aggressiveness Using The Microenvironment of Human Embryonic Stem Cells |
| 02/28/2008 | US20080050359 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| 02/28/2008 | US20080050358 Identification of Snps Associated with Hyperlipidemia, Dyslipidemia and Defective Carbohydrate Metabolism |
| 02/28/2008 | US20080050357 Systems and Methods for Antibody Engineering |
| 02/28/2008 | US20080050351 Gene Therapy Approaches to Supply Apolipoprotein A-I Agonists and Their Use to Treat Dyslipidemic Disorder |
| 02/28/2008 | US20080050350 Method for introducing an exogenous gene into a stem cell |
| 02/28/2008 | US20080050345 Adeno-associated virus serotype I nucleic acid sequences, vectors and host cells containing same |
| 02/28/2008 | US20080050343 Adeno-associated virus serotype I nucleic acid sequences, vectors and host cell containing same |
| 02/28/2008 | US20080050342 Genetic inhibition by double-stranded RNA |
| 02/28/2008 | US20080050340 Cd40 agonist antibody /type 1 interferon synergistic adjuvant combination, conjugates containing and use thereof as a therapeutic to enhance cellular immunity |